The Effects of Real-World Evidence on the Treatment of HER2+ mBC - Episode 7
Joseph Gligorov, MD, reviews advances in the treatment of advanced HER2+ breast cancer, shares his global perspective, and explains how ESMO and NCCN guidelines are similar.